Guía de práctica clínica para el diagnóstico y manejo de las infecciones de piel y tejidos blandos en Colombia

Las infecciones de piel y tejidos blandos (IPTB) representan la tercera causa de consulta por enfermedad infecciosas a los servicios médicos, después de las infecciones respiratorias y urinarias. Se presenta una guía de práctica clínica (GPC) con 38 recomendaciones basadas en la evidencia, graduadas bajo el sistema SIGN, para el diagnóstico y tratamiento de pacientes adultos con IPTB en el contexto colombiano, posterior a un proceso de adaptación de GPC publicadas y la búsqueda sistemática y síntesis de literatura para la actualización de la evidencia científica. Además, se realizó un consenso de expertos para la evaluación de las potenciales barreras para la implementación de las recomendaciones y la evaluación del grado de recomendación en el contexto local.

[1]  S. Choi,et al.  Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection , 2017, Infection & chemotherapy.

[2]  B. E. Castro,et al.  Emergence and spread of a new community-genotype methicillin-resistant Staphylococcus aureus clone in Colombia , 2017, BMC Infectious Diseases.

[3]  K. Becker,et al.  Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment , 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[4]  J. Arnaíz,et al.  [Management of furuncle, furunculosis and anthrax]. , 2015, Medicina clinica.

[5]  B. E. Castro,et al.  USA300-related methicillin-resistant Staphylococcus aureus clone is the predominant cause of community and hospital MRSA infections in Colombian children. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[6]  Jaime Robledo,et al.  Cambios a lo largo del tiempo en la distribución de los complejos de clones dominantes de Staphylococcus aureus resistente a la meticilina en Medellín, Colombia , 2013 .

[7]  E. A. Rodríguez,et al.  A comparison of methicillin-resistant and methicillin-susceptible Staphylococcus aureus reveals no clinical and epidemiological but molecular differences. , 2013, International journal of medical microbiology : IJMM.

[8]  B. E. Castro,et al.  Detection of a New Community Genotype Methicillin-Resistant Staphylococcus aureus Clone That Is Unrelated to the USA300 Clone and That Causes Pediatric Infections in Colombia , 2012, Journal of Clinical Microbiology.

[9]  E. A. Rodríguez,et al.  CC8 MRSA Strains Harboring SCCmec Type IVc are Predominant in Colombian Hospitals , 2012, PloS one.

[10]  A. Leal,et al.  Nosocomial infections caused by community-associated methicillin-resistant Staphylococcus aureus in Colombia. , 2010, American journal of infection control.

[11]  F. DeLeo,et al.  Community-associated meticillin-resistant Staphylococcus aureus , 2010, The Lancet.

[12]  Jae-Hoon Song,et al.  Hematologic malignancy as a risk factor for bacteremic skin and soft tissue infection caused by gram-negative bacilli , 2010, Annals of Hematology.

[13]  Dawn Andrews,et al.  Baseline factors predicting the duration of intravenous antibiotic therapy for cellulitis in an outpatient setting , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[14]  C. Arias,et al.  Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  D. Bessen.  Population biology of the human restricted pathogen, Streptococcus pyogenes. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[16]  E. Stobberingh,et al.  The evolution of Staphylococcus aureus. , 2008, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[17]  C. Rotstein,et al.  Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. , 2008, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[18]  J. A. Burns,et al.  Cellulitis and the role of the Clinical Microbiology Laboratory , 2007 .

[19]  P. Hsueh,et al.  Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  F. Vandenesch,et al.  Global Distribution of Panton-Valentine Leukocidin–positive Methicillin-resistant Staphylococcus aureus, 2006 , 2007, Emerging infectious diseases.

[21]  C. Arias,et al.  Community-associated Methicillin-resistant Staphylococcus aureus, Colombia , 2006, Emerging infectious diseases.

[22]  I. Gould.  Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. , 2006, International journal of antimicrobial agents.

[23]  J. Boyce,et al.  Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat , 2006, The Lancet.

[24]  J. Schrenzel,et al.  Tracking methicillin-resistant Staphylococcus aureus clones in Colombian hospitals over 7 years (1996-2003): emergence of a new dominant clone. , 2005, International journal of antimicrobial agents.

[25]  K. Ramotar,et al.  Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B Streptococcus: Implications for Reporting Susceptibility Results , 2004, Journal of Clinical Microbiology.

[26]  Marta Aires de Sousa,et al.  Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones. , 2004 .

[27]  G. Tyrrell,et al.  emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci. , 2000, Microbiology.

[28]  D. Bessen,et al.  A genetic-based evaluation of the principal tissue reservoir for group A streptococci isolated from normally sterile sites. , 1997, The Journal of infectious diseases.

[29]  E. Kaplan,et al.  The dynamics of streptococcal infections in a defined population of children: serotypes associated with skin and respiratory infections. , 1976, American journal of epidemiology.

[30]  Y. Que,et al.  Staphylococcus aureus (Including Staphylococcal toxic shock) , 2015 .

[31]  M. Swartz,et al.  95 – Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections , 2015 .

[32]  Jan V Hirschmann,et al.  Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  A. Bisno,et al.  Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  E. Castañeda,et al.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Colombian hospitals: dominance of a single unique multidrug-resistant clone. , 2001, Microbial drug resistance.

[35]  H. Akiyama,et al.  Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains. , 1999, Journal of dermatological science.

[36]  A. Bisno,et al.  Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America , 2022 .